Andere Sprachen MacroGenics, Inc.

Aktien

A1W6ND

US5560991094

MGNX

Realtime-Estimate Cboe BZX Andere Börsenplätze 18:55:04 07.05.2024			% 5 Tage	% 1. Jan.
16,18 ^USD	-1,16 %		+8,39 %	+66,53 %

26.04.	MACROGENICS, INC. : B. Riley gibt eine Kauf-Bewertung ab	ZM
09.04.	MACROGENICS, INC. : Von TD Cowen zum Kaufen aufgerüstet	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call	06.05.
MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call	03.05.
North American Morning Briefing : Traders Await -2-	10.04.
Sector Update: Health Care Stocks Mixed in Afternoon Trading	04.04.
MacroGenics Shares Surge Following Phase 2 Update on Prostate Cancer Drug	04.04.
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	04.04.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Renewed Rate Cut Hopes	04.04.
Sector Update: Health Care	04.04.
MacroGenics Says Cancer Drug Study Update Set for May After Conference Miss	03.04.
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures	03.04.
MacroGenics, Inc. Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures	03.04.
MacroGenics Narrows 2023 Net Loss, Revenue Drops; Shares Fall After-Hours	07.03.
MacroGenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07.03.
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results	07.03.
Macrogenics Insider Sold Shares Worth $813,501, According to a Recent SEC Filing	06.03.
Macrogenics Insider Sold Shares Worth $615,000, According to a Recent SEC Filing	06.03.
MacroGenics to Participate in Upcoming Investor Conferences	01.03.
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call	27.02.
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call	27.02.
Macrogenics Insider Sold Shares Worth $1,258,142, According to a Recent SEC Filing	07.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen MacroGenics, Inc.

Aktien

A1W6ND

US5560991094

MGNX

Andere Sprachen

Filter